Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bowen Acquisition CorpBOWN · Entity 79826 | Chief Financial Officer | July 11, 2023 | July 11, 2023 |
| Calisa Acquisition CorpALIS · Entity 6864 | CFO | October 21, 2025 | October 21, 2025 |
| Keyarch Acquisition CorpKYCH · Entity 110496 | Chief Financial Officer | January 24, 2022 | January 24, 2022 |
| LQR House Inc.LQR · Entity 8513 | Director | September 30, 2025 | October 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bowen Acquisition Corp
Report date July 11, 2023 · Filed July 11, 2023
This filing explicitly reported no securities owned.
Calisa Acquisition Corp
Report date October 21, 2025 · Filed October 21, 2025
This filing explicitly reported no securities owned.
Keyarch Acquisition Corp
Report date January 24, 2022 · Filed January 24, 2022
This filing explicitly reported no securities owned.
LQR House Inc.
Report date September 30, 2025 · Filed October 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 537 |
Reported balance
After 2025-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-09-30 · Exercise / conversion · Acquired 179 · Balance 537 F1: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on September 30, 2025. F3: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 892 |
Reported balance
After 2025-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-30 · Exercise / conversion · Disposed 179 · Balance 892 F1: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on September 30, 2025. F2: N/A F3: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on September 30, 2025.
F2: N/A
F3: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2025 Filed Oct 2, 2025 18:00 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionRestricted Stock Units · Derivative | 179 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-095576 · ownership.xml · derivative · entry 2 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 892 Underlying: Common Stock · 179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on September 30, 2025. F2 · derivative.expiration_date: N/A F3 · balance_after: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 18:00 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-095576 · ownership.xml · nonDerivative · entry 1 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on September 30, 2025. F3 · balance_after: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 17:41 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionRestricted Stock Units · Derivative | 179 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-061122 · ownership.xml · derivative · entry 2 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,071 Underlying: Common Stock · 179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on June 30, 2025. F2 · derivative.expiration_date: N/A F3 · balance_after: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 17:41 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-061122 · ownership.xml · nonDerivative · entry 1 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 179 restricted stock units (as adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025) granted to Dr. Lu on December 19, 2024 into 179 shares of common stock of the Issuer on June 30, 2025. F3 · balance_after: As adjusted for 1-for-35 reverse stock split effected by the Issuer on April 21, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:20 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028304 · ownership.xml · derivative · entry 2 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 6,250 restricted stock units granted to Dr. Lu on December 19, 2024 into 6,250 shares of common stock of the Issuer on March 31, 2025. F2 · derivative.expiration_date: N/A Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:20 UTC | LQR House Inc. LQR · Entity 8513 | Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028304 · ownership.xml · nonDerivative · entry 1 Lu Jing · CIK 0001869511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 6,250 restricted stock units granted to Dr. Lu on December 19, 2024 into 6,250 shares of common stock of the Issuer on March 31, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.